Skip to main content

Table 1 Baseline characteristics of the participants

From: Effect of intermittent versus continuous calorie restriction on body weight and cardiometabolic risk markers in subjects with overweight or obesity and mild-to-moderate hypertriglyceridemia: a randomized trial

Variable CCR (n = 44) ICR (n = 44) P-value
Age (years) 45.2 ± 11.7 44.0 ± 8.6 0.60
Sex (number of men) 15 10 0.34
Weight (kg) 90.1 ± 19.3 83.9 ± 13.7 0.09
BMI (kg/m2) 32.4 ± 4.6 31.6 ± 3.9 0.38
 Overweight (n) 17 17 1.0
 Obese (n) 27 27
Fat mass (%) 35.9 ± 5.8 37.5 ± 4.6 0.14
Fat-free mass (%) 63.6 ± 5.4 63.0 ± 5.9 0.60
Waist circumference (cm) 104.7 ± 11.0 100.6 ± 9.8 0.067
History of hypertension (n) 5 6 0.52
History of diabetes mellitus (n) 7 5 0.51
Medications
 Statins (n) 8 11 0.60
 ACE-I (n) 3 2 0.63
 ARB (n) 2 4 0.76
Plasma creatinine (mg/dL) 1.0 ± 0.1 1.0 ± 0.2 0.60
TG (mg/dL) 165.0 (126) 180.5 (115) 0.84
Cholesterol (mg/dL) 190.1 ± 38.1 178.6 ± 30.3 0.12
LDL-C (mg/dL) 107.7 ± 29.0 98.4 ± 28.5 0.13
HDL-C (mg/dL) 42.1 ± 10.6 39.1 ± 7.7 0.13
FBS (mg/dL) 89.5 (16) 88.0 (26) 0.18
Insulin (μIU/mL) 22.0 ± 9.7 18.2 ± 8.1 0.046
HOMA-IR 3.7 (3) 3.5 (3) 0.37
  1. Data presented as mean ± SD, median (interquartile range) or percentages for dichotomous measures
  2. ACE-I Angiotensin-converting enzyme inhibitor, ARB Angiotensin receptor blocker, BMI body mass index, CCR Continous calorie restriction diet, HDL-C high-density lipoprotein cholesterol, HOMA-IR homeostasis model assessment of insulin resistance, ICR Intermittent calorie restriction diet, LDL-C low-density lipoprotein cholesterol, TG triglycerides